# Processa Pharmaceuticals, Inc.: filings

PCSA · Nasdaq · CIK 1533743 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pcsa.md) · [Financials](/companies/pcsa/financials.md) · [Filings](/companies/pcsa/filings.md) · [Insiders](/companies/pcsa/insiders.md)

## Reports and events: 256 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 238, 8-K 156, 10-Q 40, 4/A 38, CORRESP 25, UPLOAD 19, 3 16, D 14, S-1/A 14, 10-K 13, DEF 14A 11, EFFECT 10, DEFA14A 8, PRE 14A 7, 8-K/A 6, S-1 6, S-8 6, SCHEDULE 13G/A 6, 10-K/A 5, 424B5 5, NT 10-Q 5, SCHEDULE 13G 5, 3/A 4, 424B3 4, 424B4 4, S-3 4, DEF 14C 3, NT 10-K 3, PRE 14C 3, SC 13G 3, D/A 2, SC 13G/A 2, SCHEDULE 13D/A 2, 10-Q/A 1, 8-A12B 1, ARS 1, CERT 1, DEFR14A 1, DRS 1, DRSLTR 1, PRER14A 1, RW 1, RW WD 1, S-1MEF 1, SC 13D 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:37 ET | [DEF 14A](/filings/0001140361-26-040520.md) | Proxy statement, period 2026-11-30 | 0001140361-26-040520 |
| 2026-10-05 | 07:21 ET | [8-K/A](/filings/0001140361-26-038535.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-038535 |
| 2026-08-14 | 16:06 ET | [10-Q](/filings/0001493152-26-038334.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038334 |
| 2026-08-04 | 17:25 ET | [8-K](/filings/0001493152-26-036032.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036032 |
| 2026-07-29 | 07:35 ET | [8-K](/filings/0001493152-26-035099.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035099 |
| 2026-06-18 | 16:05 ET | [DEF 14A](/filings/0001493152-26-029326.md) | Proxy statement, period 2026-06-18 | 0001493152-26-029326 |
| 2026-05-07 | 16:18 ET | [10-Q](/filings/0001493152-26-021721.md) | Quarterly report, period 2026-03-31 | 0001493152-26-021721 |
| 2026-04-30 | 17:14 ET | [10-K/A](/filings/0001493152-26-020731.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-020731 |
| 2026-04-30 | 17:11 ET | [8-K](/filings/0001493152-26-020728.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-020728 |
| 2026-03-18 | 16:05 ET | [10-K](/filings/0001493152-26-011204.md) | Annual report, period 2025-12-31 | 0001493152-26-011204 |
| 2026-02-23 | 11:00 ET | [SCHEDULE 13D/A](/filings/0002081456-26-000002.md) | Ownership report, active investor, amended | 0002081456-26-000002 |
| 2026-02-19 | 16:05 ET | [8-K](/filings/0001493152-26-007469.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-007469 |
| 2026-01-07 | 08:30 ET | [8-K](/filings/0001493152-26-000733.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000733 |
| 2025-12-15 | 11:00 ET | [8-K](/filings/0001493152-25-027680.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-027680 |
| 2025-11-06 | 16:07 ET | [10-Q](/filings/0001493152-25-021069.md) | Quarterly report, period 2025-09-30 | 0001493152-25-021069 |
| 2025-10-15 | 12:28 ET | [SCHEDULE 13D/A](/filings/0002081456-25-000003.md) | Ownership report, active investor, amended | 0002081456-25-000003 |
| 2025-09-16 | 10:19 ET | [8-K/A](/filings/0001493152-25-013648.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013648 |
| 2025-09-12 | 19:45 ET | [8-K](/filings/0001493152-25-013108.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013108 |
| 2025-09-10 | 10:42 ET | [8-K](/filings/0001493152-25-012966.md) | 5.07 Shareholder vote results | 0001493152-25-012966 |
| 2025-09-02 | 17:13 ET | [8-K](/filings/0001493152-25-012567.md) | 5.07 Shareholder vote results | 0001493152-25-012567 |
| 2025-08-25 | 17:21 ET | [8-K](/filings/0001641172-25-025421.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-025421 |
| 2025-08-14 | 08:30 ET | [8-K/A](/filings/0001641172-25-023736.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023736 |
| 2025-08-13 | 14:50 ET | [SCHEDULE 13D](/filings/0002081456-25-000001.md) | Ownership report, active investor | 0002081456-25-000001 |
| 2025-08-13 | 08:30 ET | [DEF 14A](/filings/0001493152-25-011883.md) | Proxy statement, period 2025-08-13 | 0001493152-25-011883 |
| 2025-08-08 | 17:17 ET | [8-K](/filings/0001493152-25-011775.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-25-011775 |
| 2025-08-07 | 08:52 ET | [10-Q](/filings/0001493152-25-011685.md) | Quarterly report, period 2025-06-30 | 0001493152-25-011685 |
| 2025-08-07 | 08:30 ET | [8-K](/filings/0001493152-25-011680.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011680 |
| 2025-07-25 | 16:05 ET | [8-K](/filings/0001493152-25-011419.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011419 |
| 2025-07-18 | 16:15 ET | [8-K](/filings/0001493152-25-011305.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-011305 |
| 2025-07-15 | 12:32 ET | [8-K](/filings/0001641172-25-019663.md) | 5.07 Shareholder vote results | 0001641172-25-019663 |
| 2025-07-01 | 09:00 ET | [8-K](/filings/0001641172-25-017288.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017288 |
| 2025-06-30 | 17:08 ET | [8-K](/filings/0001641172-25-017185.md) | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-017185 |
| 2025-06-18 | 17:29 ET | [8-K](/filings/0001641172-25-015654.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015654 |
| 2025-06-17 | 10:32 ET | [8-K](/filings/0001641172-25-015355.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015355 |
| 2025-06-13 | 08:01 ET | [S-1](/filings/0001641172-25-014967.md) | Registration statement | 0001641172-25-014967 |
| 2025-05-12 | 16:05 ET | [DEF 14A](/filings/0001641172-25-009671.md) | Proxy statement, period 2025-05-12 | 0001641172-25-009671 |
| 2025-05-08 | 16:06 ET | [10-Q](/filings/0001641172-25-009252.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009252 |
| 2025-03-20 | 16:31 ET | [10-K](/filings/0001641172-25-000070.md) | Annual report, period 2024-12-31 | 0001641172-25-000070 |
| 2025-02-11 | 10:32 ET | [8-K](/filings/0001493152-25-005830.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005830 |
| 2025-02-10 | 16:05 ET | [8-K](/filings/0001493152-25-005633.md) | 3.01 Delisting notice | 0001493152-25-005633 |
| 2025-01-30 | 17:20 ET | [8-K](/filings/0001493152-25-004298.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-004298 |
| 2025-01-27 | 08:34 ET | [S-1/A](/filings/0001493152-25-003720.md) | Registration statement, amended | 0001493152-25-003720 |
| 2025-01-16 | 06:24 ET | [S-1/A](/filings/0001493152-25-002455.md) | Registration statement, amended | 0001493152-25-002455 |
| 2024-12-20 | 16:31 ET | [S-1](/filings/0001493152-24-051075.md) | Registration statement | 0001493152-24-051075 |
| 2024-11-06 | 16:00 ET | [8-K](/filings/0001493152-24-043821.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-043821 |
| 2024-10-30 | 16:05 ET | [10-Q](/filings/0001493152-24-043058.md) | Quarterly report, period 2024-09-30 | 0001493152-24-043058 |
| 2024-10-02 | 16:36 ET | [8-K](/filings/0001493152-24-039220.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039220 |
| 2024-08-28 | 08:00 ET | [8-K](/filings/0001493152-24-034115.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034115 |
| 2024-08-13 | 16:15 ET | [10-Q](/filings/0001493152-24-031622.md) | Quarterly report, period 2024-06-30 | 0001493152-24-031622 |
| 2024-07-30 | 08:00 ET | [8-K](/filings/0001493152-24-029514.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029514 |

Page 1 of 6. [Older](/companies/pcsa/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:47 ET. No prices; not investment advice.